Stem cell-conditioned medium does not protect against kidney failure

Cell Biology International

Volumn 35, Issue 3, 2011, Pages 209-213

  Gheisari, Yousof ^a   Ahmadbeigi, Naser ^a,b   Naderi, Mahmood ^a   Nassiri, Seyed Mahdi ^c   Nadri, Samad ^a   Soleimani, Masoud ^d  

^a STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

^b SABZ Biomedicals   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Conditioned culture media; Kidney failure; Mesenchymal stem cell; Paracrine communication

Indexed keywords

CISPLATIN; CREATININE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CREATININE BLOOD LEVEL; CULTURE MEDIUM; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; KIDNEY FAILURE; KIDNEY INJURY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; RENAL PROTECTION; SOMATIC CELL; STEM CELL; STEM CELL CONDITIONED MEDIUM; TREATMENT FAILURE; TREATMENT RESPONSE; UMBILICAL CORD BLOOD; UNRESTRICTED SOMATIC STEM CELL; UREA BLOOD LEVEL;

ANIMALS; CISPLATIN; CREATININE; CULTURE MEDIA, CONDITIONED; FETAL BLOOD; HUMANS; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; PARACRINE COMMUNICATION; RENAL INSUFFICIENCY; STEM CELLS; UREA;

EID: 79957623134     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100183     Document Type: Article

References (21)

1. Behr L, Hekmati M, Fromont G, Borenstein N, Noel LH, Lelievre-Pegorier M, Laborde K. Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney. Nephron Physiol 2007;107:65-76.
2. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007;18:2486-96.
3. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-84.
4. Castellani S, Adams PM. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur J Pharmacol 1981;73:143-54.
5. Chatterjee PK, Brown PA, Cuzzocrea S, Zacharowski K, Stewart KN, Mota-Filipe H et al. Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int 2001;59:2073-83.
6. Chen J, Park HC, Addabbo F, Ni J, Pelger E, Li H et al. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int 2008;74:879-89.
7. Curtis LM, Chen S, Chen B, Agarwal A, Klug CA, Sanders PW. Contribution of intrarenal cells to cellular repair after acute kidney injury: subcapsular implantation technique. Am J Physiol Renal Physiol 2008;295:F310-4.
8. Dai W, Hale SL, Kloner RA. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med 2007;2:63-8.
9. Duffield JS, Park KM, HsiaO LL, Kelley VR, Scadden DT, Ichimura T et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrowderived stem cells. J Clin Invest 2005;115:1743-55.
10. Faubel S, Lewis EC, Reznikov L, Ljubanovic D, Hoke TS, Somerset H et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 2007;322:8-15.
11. Gheisari Y, Soleimani M, Azadmanesh K, Zeinali S. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy 2008;10:815-23.
12. Hammerman MR. Tissue engineering the kidney. Kidney Int 2003;63:1195-204.
13. Hashemi SM, Soleimani M, Zargarian SS, Haddadi-Asl V, Ahmadbeigi N, Soudi S et al. In vitro differentiation of human cord blood-derived unrestricted somatic stem cells into Hepatocyte-like cells on poly(epsilon-caprolactone) nanofiber scaffolds. Cells Tissues Organs 2009;190:135-49.
14. Imai E, Iwatani H. The continuing story of renal repair with stem cells. J Am Soc Nephrol 2007;18:2423-4.
15. Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 2000;20:4-19.
16. Kinomura M, Kitamura S, Tanabe K, Ichinose K, Hirokoshi K, Takazawa Y et al. Amelioration of cisplatin-induced acute renal injury by renal progenitor-like cells derived from the adult rat kidney. Cell Transplant 2008;17:143-58.
17. Kögler G, Radke TF, Lefort A, Sensken S, Fischer J, Sorg RV et al. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 2005;33:573-83.
18. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-6.
19. Parekkadan B, Van PD, Suganuma K, Carter EA, Berthiaume F, Tilles AW et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE 2007;2:e941.
20. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005;289:F31-42.
21. Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007;292:F1626-35.